Cookson Peirce & Co’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4M | Buy |
267,535
+45,408
| +20% | +$5.49M | 1.42% | 23 |
|
|
2025
Q1 | $24.8M | Buy |
+222,127
| New | +$24.8M | 1.25% | 29 |
|
|
2024
Q4 | – | Sell |
-7,056
| Closed | -$812K | – | 294 |
|
|
2024
Q3 | $812K | Buy |
7,056
+9
| +0.1% | +$1.04K | 0.04% | 124 |
|
|
2024
Q2 | $750K | Sell |
7,047
-173
| -2% | -$18.4K | 0.04% | 123 |
|
|
2024
Q1 | $698K | Sell |
7,220
-42
| -0.6% | -$4.06K | 0.04% | 129 |
|
|
2023
Q4 | $733K | Buy |
7,262
+127
| +2% | +$12.8K | 0.04% | 120 |
|
|
2023
Q3 | $727K | Buy |
+7,135
| New | +$727K | 0.05% | 120 |
|
|
2022
Q3 | – | Sell |
-175,674
| Closed | -$14.9M | – | 212 |
|
|
2022
Q2 | $14.9M | Buy |
+175,674
| New | +$14.9M | 1.02% | 40 |
|
|
2020
Q3 | – | Sell |
-6,756
| Closed | -$590K | – | 155 |
|
|
2020
Q2 | $590K | Sell |
6,756
-197
| -3% | -$17.2K | 0.06% | 99 |
|
|
2020
Q1 | $573K | Buy |
6,953
+347
| +5% | +$28.6K | 0.07% | 89 |
|
|
2019
Q4 | $626K | Buy |
6,606
+105
| +2% | +$9.95K | 0.06% | 112 |
|
|
2019
Q3 | $565K | Buy |
6,501
+531
| +9% | +$46.1K | 0.05% | 113 |
|
|
2019
Q2 | $545K | Buy |
5,970
+2,971
| +99% | +$271K | 0.05% | 115 |
|
|
2019
Q1 | $258K | Buy |
2,999
+198
| +7% | +$17K | 0.02% | 136 |
|
|
2018
Q4 | $215K | Buy |
+2,801
| New | +$215K | 0.02% | 145 |
|